ACADIA PHARMACEUTICALS INC
ACADIA PHARMACEUTICALS INC
ACADIA PHARMACEUTICALS INC (ACAD) — SEC Financial Statements & Analysis
ACADIA PHARMACEUTICALS INC (ACAD) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 282 | 178 | 258 | 254 | 218 | 320 | 155 | 177 | 205 | 189 | 98 | 108 | |||||
Available For Sale Securities Debt Securities Curr… | 569 | 642 | 589 | 508 | 464 | 436 | 410 | 324 | 266 | 250 | 248 | 267 | |||||
Accounts Receivable Net Current | 135 | 121 | 116 | 108 | 106 | 99 | 98 | 104 | 95 | 98 | 93 | 82 | |||||
Interest Receivable Current | 13 | 27 | 24 | 12 | 8 | 6 | 12 | 7 | 5 | 4 | 2 | 2 | |||||
Prepaid Expense Current | 65 | 60 | 61 | 53 | 53 | 56 | 52 | 46 | 43 | 39 | 38 | 24 | |||||
Assets Current | 1,096 | 1,062 | 1,076 | 961 | 871 | 938 | 788 | 729 | 675 | 616 | 499 | 493 | |||||
Property Plant And Equipment Net | 15 | 8 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | |||||
Operating Lease Right Of Use Asset | 46 | 47 | 50 | 51 | 51 | 47 | 44 | 52 | 54 | 52 | 51 | 52 | |||||
Finite Lived Intangible Assets Net | 106 | 109 | 112 | 114 | 117 | 120 | 106 | 108 | 110 | 65 | 67 | 68 | |||||
Restricted Cash Noncurrent | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 6 | 6 | 6 | 6 | 8 | |||||
Inventory For Long Term Contracts Or Programs | 81 | 77 | 77 | 84 | 80 | 70 | 26 | 15 | 5 | 5 | 5 | 5 | |||||
Deferred Income Tax Assets Net | 250 | 250 | - | - | - | 0 | - | - | - | - | - | - | |||||
Other Assets Noncurrent | 4 | 4 | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | |||||
Assets | 1,605 | 1,564 | 1,331 | 1,226 | 1,132 | 1,188 | 977 | 914 | 855 | 749 | 633 | 643 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | 12 | 11 | 22 | 20 | 18 | 16 | 19 | 20 | 19 | 18 | 12 | 19 | |||||
Accrued Liabilities Current | 293 | 266 | 335 | 310 | 284 | 379 | 325 | 318 | 311 | 237 | 197 | 169 | |||||
Liabilities Current | 306 | 277 | 357 | 330 | 303 | 395 | 344 | 338 | 331 | 254 | 210 | 188 | |||||
Operating Lease Liability Noncurrent | 39 | 41 | 43 | 45 | 45 | 42 | 40 | 47 | 49 | 48 | 48 | 50 | |||||
Other Liabilities Noncurrent | 13 | 19 | 14 | 29 | 20 | 18 | 15 | 12 | 11 | 15 | 13 | 9 | |||||
Liabilities | 357 | 337 | 413 | 403 | 367 | 455 | 400 | 397 | 391 | 317 | 270 | 247 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 3,058 | 3,039 | 3,003 | 2,981 | 2,950 | 2,937 | 2,924 | 2,898 | 2,879 | 2,863 | 2,839 | 2,808 | |||||
Retained Earnings Accumulated Deficit | -1,810 | -1,813 | -2,087 | -2,159 | -2,185 | -2,204 | -2,348 | -2,381 | -2,414 | -2,431 | -2,477 | -2,411 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -1 | 1 | 1 | 0 | 0 | 0 | 1 | -0 | -0 | 0 | -0 | -1 | |||||
Stockholders Equity | 1,248 | 1,227 | 917 | 822 | 765 | 733 | 577 | 517 | 464 | 432 | 362 | 396 | |||||
Liabilities And Stockholders Equity | 1,605 | 1,564 | 1,331 | 1,226 | 1,132 | 1,188 | 977 | 914 | 855 | 749 | 633 | 643 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 225 | 225 | 225 | 225 | 225 | 225 | 225 | 225 | 225 | 225 | 225 | 225 | |||||
Common Stock Shares Issued | 171 | 170 | 169 | 169 | 167 | 167 | 166 | 166 | 165 | 165 | 164 | 163 | |||||
Shares Outstanding | 171 | 170 | 169 | 169 | 167 | 167 | 166 | 166 | 165 | 165 | 164 | 163 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.99% | 12.23% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 27.41% | 30.66% | 37.33% | 6.52% | -13.73% | -9.75% | 15.66% | 27.58% | 23.97% | -15.83% | -10.02% | -13.15% |
| 2024 | -0.72% | 6.84% | 25.84% | 9.29% | 3.43% | -5.47% | -5.12% | -1.45% | 8.55% | -13.19% | -23.84% | 15.10% |
| 2023 | 14.20% | 11.14% | 34.76% | 5.15% | -13.38% | -18.53% | -7.40% | 30.45% | 13.38% | -24.42% | -29.18% | -37.73% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 3.59 | 3.83 | 3.02 | 2.91 | 2.88 | 2.38 | 2.29 | 2.16 | 2.04 | 2.42 | 2.38 | 2.62 | |||||
| Quick Ratio | 3.38 | 3.62 | 2.85 | 2.75 | 2.70 | 2.24 | 2.14 | 2.02 | 1.91 | 2.27 | 2.20 | 2.49 | |||||
| Working Capital | 790.49M | 785.00M | 719.84M | 630.53M | 568.41M | 543.45M | 444.34M | 391.07M | 344.70M | 361.87M | 289.57M | 304.69M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.29 | 0.27 | 0.45 | 0.49 | 0.48 | 0.62 | 0.69 | 0.77 | 0.84 | 0.73 | 0.75 | 0.62 | |||||
| Debt Ratio | 0.22 | 0.22 | 0.31 | 0.33 | 0.32 | 0.38 | 0.41 | 0.43 | 0.46 | 0.42 | 0.43 | 0.38 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.80 | 0.78 | 0.91 | 0.95 | 1.00 | 0.99 | 1.15 | 1.14 | 1.08 | 1.09 | 1.02 | 0.88 | |||||
| Days Sales Outstanding TTM | 40.17 | 37.50 | 37.31 | 37.83 | 36.72 | 37.54 | 37.51 | 38.03 | 36.02 | 40.31 | 42.90 | 49.63 | |||||
| Receivables Turnover TTM | 9.09 | 9.73 | 9.78 | 9.65 | 9.94 | 9.72 | 9.73 | 9.60 | 10.13 | 9.05 | 8.51 | 7.35 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 2.18 | 2.30 | 1.53 | 1.32 | 1.37 | 1.36 | 0.77 | 0.18 | -0.01 | -0.37 | -0.91 | -0.67 | |||||
| Free Cash Flow Per Share TTM | 0.67 | 0.04 | 0.59 | 0.53 | 0.30 | 0.95 | 1.22 | 0.49 | 0.14 | -0.14 | -0.81 | -0.45 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 91.47% | 91.69% | 91.92% | 91.97% | 92.04% | 91.46% | 91.61% | 91.72% | 92.27% | 94.27% | 95.86% | 97.52% | |||||
| Operating Profit Margin TTM | 7.39% | 9.78% | 23.01% | 23.24% | 23.58% | 24.10% | 12.08% | 2.56% | -0.56% | -10.10% | -24.43% | -23.14% | |||||
| Net Profit Margin TTM | 34.30% | 36.49% | 24.94% | 21.80% | 22.97% | 23.64% | 13.83% | 3.43% | -0.21% | -8.44% | -23.55% | -20.12% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 9.93% | 11.87% | 12.69% | 14.41% | 22.42% | 31.85% | 47.06% | 61.65% | 56.43% | 40.45% | 23.54% | 7.51% | |||||
| Net Income Growth (1Y) | 64.12% | 72.66% | 103.24% | 626.84% | -13,484.97% | -469.50% | -186.36% | -127.58% | -98.83% | -71.62% | -31.53% | -45.84% | |||||
| EPS Growth (1Y) | 60.55% | 69.96% | 99.79% | 616.99% | -13,323.68% | -465.27% | -185.45% | -127.23% | -98.85% | -71.99% | -32.53% | -46.44% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 10.10 | 11.50 | 13.80 | 16.29 | 12.11 | 13.43 | 19.86 | 88.02 | -1,781.94 | -83.69 | -23.00 | -35.33 | |||||
| P/B | 3.04 | 3.66 | 3.93 | 4.40 | 3.62 | 4.15 | 4.42 | 5.21 | 6.57 | 11.88 | 9.45 | 9.89 | |||||
| P/S TTM | 3.47 | 4.20 | 3.44 | 3.55 | 2.78 | 3.17 | 2.75 | 3.02 | 3.74 | 7.06 | 5.42 | 7.11 | |||||
| Market Cap | 3.80B | 4.50B | 3.60B | 3.62B | 2.77B | 3.04B | 2.55B | 2.69B | 3.05B | 5.13B | 3.42B | 3.91B | |||||
| Enterprise Value | 3.51B | 4.32B | 3.34B | 3.37B | 2.55B | 2.72B | 2.40B | 2.51B | 2.84B | 4.94B | 3.32B | 3.81B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 113.59M | 6.31M | 98.97M | 88.25M | 49.60M | 157.20M | 202.66M | 80.48M | 23.66M | -23.35M | -132.59M | -74.31M | |||||
| Net Debt | -282.21M | -177.70M | -258.00M | -253.64M | -217.70M | -319.59M | -155.15M | -177.13M | -204.75M | -188.66M | -98.19M | -107.94M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data